- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Pan-Macrophage Antibody D11 / Histiocyte Marker Monoclonal Antibody recognizes an antigen associated with cells of the human monocyte/macrophage lineage. Originally characterized as an antimacrophage monoclonal antibody, clone D11 reacts with circulating monocytes and resident macrophages in numerous tissues. The antigen has not been assigned a definitive molecular identity, distinguishing D11 from antibodies directed against established macrophage proteins such as CD68. Its restricted staining pattern has made it useful in research examining macrophage differentiation, tissue distribution, and histiocytic cell populations.
Macrophages are specialized immune cells involved in phagocytosis, antigen processing, inflammatory regulation, and maintenance of tissue homeostasis. They arise through multiple developmental pathways and acquire distinct characteristics in response to local environmental signals. Resident macrophages contribute to tissue surveillance and removal of cellular debris, while recruited monocyte-derived macrophages participate in inflammatory responses and tissue repair. Identifying these populations is important for understanding how macrophage differentiation and activation influence normal physiology and disease-associated processes.
Studies characterizing clone D11 demonstrated antigen localization at the plasma membrane and within cytoplasmic compartments, including lysosomes. Immunoblot analysis identified an approximately 125 kDa antigen in human liver and a 135 kDa protein in tumors of histiocytic origin. These findings suggest that the recognized antigen may exhibit differences in molecular characteristics among tissue and pathological contexts, although the underlying molecular basis has not been established. D11 also differs from several other macrophage markers in its reported recognition pattern, including a lack of staining in Langerhans cells.
The antibody has been investigated in studies of hematologic malignancies and tumors exhibiting histiocytic differentiation. Although D11 recognizes histiocytic tumors, published investigations have also documented reactivity in certain neoplasms of other origins. Consequently, positive staining should not be interpreted as definitive evidence of histiocytic lineage without additional markers and appropriate morphological context. Its staining characteristics nevertheless provide information relevant to research on monocyte/macrophage differentiation and the immunophenotypic properties of tumor-associated cell populations.
NSJ Bioreagents offers this Pan-Macrophage Antibody for investigating macrophage distribution, histiocytic differentiation, and cellular populations associated with inflammatory and neoplastic processes. Its recognition of an antigen distinct from CD68 provides a complementary approach to examining macrophage-associated phenotypes.
Explore our Immunology Antibodies for additional research tools targeting macrophage-associated proteins, immune cell differentiation markers, and regulators of inflammatory responses.
Optimal dilution of the Pan-Macrophage Antibody D11 / Histiocyte Marker Monoclonal Antibody should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A membrane preparation from human hepatocytes was used as the immunogen for the Macrophage / Histiocytoma Marker antibody.
Store the Macrophage / Histiocytoma Marker antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Macrophage marker antibody, Histiocyte marker antibody, Macrophage/Histiocytoma marker antibody, Anti-macrophage antibody, Monocyte/macrophage marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.